Going beyond the binary distinction between U-CLL versus M-CLL, increasing evidence supports the theory that BcR IG stereotypy may assist in refining risk stratification, given that cases belonging to the same stereotypd subset share several clinical and biological features, including recurrent SHMs (12, 21–23). Here, BCR is linked to B-cell chronic lymphocytic leukemia.